HDAC inhibitors can further synergize with DHA to induce endogenous retrovirus transcription, promote chemokine-dependent T cell infiltration and favor T cell memory and effector phenotypes, thereby reverting immune evasion in non-small-cell lung carcinoma (NSCLC) models [35]. The gene discussed is HDAC9; the disease is non-small cell lung carcinoma.